Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 1396 AL 1410

Outcomes of rehabilitation following device-aided therapy start in parkinson's disease: a randomized controlled trial

Björkdahl A, Khalif A, Gustafsson M, Lindström AC, Bergquist F.

J Rehabil Med. 2026 Aug 3;58:jrm46068. doi: 10.2340/jrm.v58.46068.

Comparative pharmacovigilance of Levodopa and Pramipexole: a disproportionality analysis of the FAERS database

Hu L, Ren Y, Li Y, Cai F.

Neurol Sci. 2026 Aug 4;47(8):679. doi: 10.1007/s10072-026-09295-8.

Toward the prevention of clinically manifest Parkinson's disease

Höglinger G, Hopfner F.

J Neural Transm (Vienna). 2026 Aug 4. doi: 10.1007/s00702-026-03240-x. Online ahead of print.

Therapeutic potential of spirulina and its bioactive compound phycocyanin in neuropsychiatric disorders

Talebi Taheri A, Motamedzadeh A, Zahedi E, Farasat A, Dadgostar E, Aschner M, Khanifar H, Rahmati-Dehkordi F, Tamtaji OR.

Mol Biol Rep. 2026 Aug 4;53(1):1332. doi: 10.1007/s11033-026-12532-0.

The glymphatic system and Parkinson's disease: a narrative review

Acaroglu MA, Abdelghaffar T, Samanci B, Zirh A, Samanci Y, Yilmaz NH.

Neurol Sci. 2026 Aug 5;47(8):680. doi: 10.1007/s10072-026-09291-y.

Exploring the Link Between Obstructive Sleep Apnea and Neuropsychiatric Disorders: Role of Neuroinflammatory Mechanisms

Mehdi MR, Al-Qassab ZMS, Sabuni O, Rai M, Patel T, Patel R, Iftikhar L.

Cureus. 2026 Jul 5;18(7):e112096. doi: 10.7759/cureus.112096. eCollection 2026 Jul.

Cognitive training and promoting a healthy lifestyle in isolated REM sleep behavior disorder: The randomized controlled trial CogTrAiL-RBD

Ophey A, Röttgen S, Kufer K, Pauquet J, Scharfenberg D, Armbrust P, Kammerzell A, Knopf N, Kollath S, Sommer P, Doppler CEJ, Farrher E, Seger A, Shah NJ, Zopfs D, Reetz K, Fink GR, Sommerauer M, Kalbe E.

Alzheimers Dement. 2026 Aug;22(8):e71707. doi: 10.1002/alz.71707.

A single-domain antibody targets aggregation-prone region of α-synuclein to reduce synucleinopathy, rescue neurodegeneration and improve function

Pragati, Congdon EE, Jiang Y, Erdjument-Bromage H, Huang HW, Pan R, Marchal IS, Kong XP, Neubert TA, Ryoo HD, Sigurdsson EM.

bioRxiv [Preprint]. 2026 Jul 10:2026.07.07.735601. doi: 10.64898/2026.07.07.735601.

Functional nanoprobes for early diagnosis and precision theranostics of Parkinson's disease: a review of material strategies and multimodal sensing

Zeng M, Chen T, Wang Y, Hu C, Yin X, Shen C, Wang X.

J Mater Chem B. 2026 Aug 5. doi: 10.1039/d6tb00813e. Online ahead of print.

Guiding pluripotent stem cell therapies past the immune system

Pizzato HA, Bhattacharya D.

Stem Cells Transl Med. 2026 Jul 20;15(8):szag051. doi: 10.1093/stcltm/szag051.

Cross-link Between CircRNAs and Neuroinflammation in Parkinson's Disease

El-Ashmawy NE, Khedr EG, Darwish RT, Ibrahim AO.

Mol Neurobiol. 2026 Aug 6;63(1):814. doi: 10.1007/s12035-026-06085-3.

Targeting mitochondrial ribosomal proteins: a functional and translational framework for neurodegenerative disease research

Del Giudice L, Guida M, Aletta MR, Pontieri P.

Front Neurol. 2026 Jul 22;17:1882474. doi: 10.3389/fneur.2026.1882474. eCollection 2026.

Locus Coeruleus as a Master Regulator of Diverse Functions in the Central Nervous System: Its Relevance in Ageing and Neurodegenerative Disorders

Bhattacharya A, Manjithaya R, Chickabasaviah Y, Alladi PA.

Ann Neurosci. 2026 Aug 4:09727531261462296. doi: 10.1177/09727531261462296. Online ahead of print.

Multifunctional nanozyme platforms in central nervous system therapies: from rational design to translational medicine

Niu S, Liu X, Xu R, Zhu A, Zhu S, Hu F, Ding K, Li S, Zhu B, Liang P, Zhang S, Xiao A, Fan K, Zhang Z.

Theranostics. 2026 Jul 29;16(14):8385-8426. doi: 10.7150/thno.136080. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias